GIA AMANE: Open Payments
NPI 1205327202 · SUGARLOAF, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 15 payments from 6 companies in 2025. Trend: 2023 $2,170 · 2024 $3,299 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $213 |
| Galderma Laboratories, L.P. | 1 | $146 |
| ABBVIE INC. | 2 | $39 |
| GENZYME CORPORATION | 1 | $39 |
| PFIZER INC. | 1 | $22 |
| Incyte Corporation | 1 | $16 |
Products named: Bimzelx, NEMLUVIO, RINVOQ, DUPIXENT, CIBINQO, OPZELURA.
Industry payments across PA — which companies pay providers there.
